Cargando…

KIF15 promotes bladder cancer proliferation via the MEK–ERK signaling pathway

BACKGROUND: Bladder cancer (BC) is the most common cancer of the urinary tract and invariably predicts a poor prognosis. In this study, we found a reliable gene signature and potential biomarker for predicting clinical prognosis. METHODS: The gene expression profiles were obtained from the GEO datab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hongda, Bo, Qiyu, Wu, Zonglong, Liu, Qinggang, Li, Yan, Zhang, Ning, Guo, Hu, Shi, Benkang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396666/ https://www.ncbi.nlm.nih.gov/pubmed/30881113 http://dx.doi.org/10.2147/CMAR.S191681

Ejemplares similares

KIF15 promotes pancreatic cancer proliferation via the MEK–ERK signalling pathway
por: Wang, Jie, et al.
Publicado: (2017)

PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer
por: Zhang, Hanpu, et al.
Publicado: (2022)

Anti-aging Effects of Alu Antisense RNA on Human Fibroblast Senescence Through the MEK-ERK Pathway Mediated by KIF15
por: Ji, Ning, et al.
Publicado: (2023)

Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer
por: Wu, Zonglong, et al.
Publicado: (2020)

TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway
por: Tang, Li, et al.
Publicado: (2023)

Effect of KIF22 on promoting proliferation and migration of gastric cancer cells via MAPK-ERK pathways
por: Yu, Ze-Yuan, et al.
Publicado: (2020)

Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis
por: Wu, Zonglong, et al.
Publicado: (2020)

KIF22 Promotes Development of Pancreatic Cancer by Regulating the MEK/ERK/P21 Signaling Axis
por: Zhang, Ruiyun, et al.
Publicado: (2022)

Fragile X mental retardation protein promotes astrocytoma proliferation via the MEK/ERK signaling pathway
por: Xing, Zhou, et al.
Publicado: (2016)

KIF15 Promotes Proliferation and Growth of Hepatocellular Carcinoma
por: Sun, Yue-Feng, et al.
Publicado: (2020)

BCKDK Promotes Ovarian Cancer Proliferation and Migration by Activating the MEK/ERK Signaling Pathway
por: Li, Huashun, et al.
Publicado: (2022)

LncRNA HOTTIP promotes the proliferation and invasion of ovarian cancer cells by activating the MEK/ERK pathway
por: Liu, Jian, et al.
Publicado: (2020)

TTYH3 Modulates Bladder Cancer Proliferation and Metastasis via FGFR1/H-Ras/A-Raf/MEK/ERK Pathway
por: Biswas, Polash Kumar, et al.
Publicado: (2022)

Following Nerve Injury Neuregulin-1 Drives Microglial Proliferation and Neuropathic Pain via the MEK/ERK Pathway
por: Calvo, Margarita, et al.
Publicado: (2011)

PDRG1 promotes the proliferation and migration of GBM cells by the MEK/ERK/CD44 pathway
por: Sun, Jinmin, et al.
Publicado: (2021)

COPS3 Promotes Proliferation, Invasion, and EMT of Colorectal Cancer Cells by MEK/ERK Pathway
por: Xie, Yanchao, et al.
Publicado: (2022)

KIF5A Promotes Bladder Cancer Proliferation In Vitro and In Vivo
por: Tian, Da-Wei, et al.
Publicado: (2019)

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway
por: Wang, Da, et al.
Publicado: (2021)

LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway
por: Chen, Ziye, et al.
Publicado: (2021)

Midazolam impedes lung carcinoma cell proliferation and migration via EGFR/MEK/ERK signaling pathway
por: Zhang, Xiangchao, et al.
Publicado: (2023)

RASSF9 promotes NSCLC cell proliferation by activating the MEK/ERK axis
por: Yuan, Jun, et al.
Publicado: (2021)

Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway
por: Gu, Jun, et al.
Publicado: (2016)

RNF128 Promotes Malignant Behaviors via EGFR/MEK/ERK Pathway in Hepatocellular Carcinoma
por: Bai, Xue-Song, et al.
Publicado: (2020)

KIF20A Affects the Prognosis of Bladder Cancer by Promoting the Proliferation and Metastasis of Bladder Cancer Cells
por: Shen, Tianyu, et al.
Publicado: (2019)

The MEK/ERK Pathway Promotes NOTCH Signalling in Pancreatic Cancer Cells
por: Tremblay, Isabelle, et al.
Publicado: (2013)

Dabrafenib Promotes Schwann Cell Differentiation by Inhibition of the MEK-ERK Pathway
por: Park, Kyuhee, et al.
Publicado: (2021)

TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway
por: Xu, Dahai, et al.
Publicado: (2022)

EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2019)

SCF promotes the production of IL-13 via the MEK-ERK-CREB signaling pathway in mast cells
por: Wang, Yimeng, et al.
Publicado: (2019)

Growth hormone receptor promotes breast cancer progression via the BRAF/MEK/ERK signaling pathway
por: Zhu, Xiaojue, et al.
Publicado: (2020)

Single‐cell transcriptomes of mouse bladder urothelium uncover novel cell type markers and urothelial differentiation characteristics
por: Li, Yan, et al.
Publicado: (2021)

FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway
por: Li, Yang, et al.
Publicado: (2022)

CCNY Accelerates Cylcin E Expression to Regulate the Proliferation of Laryngeal Carcinoma Cells via MEK/ERK Signaling Pathway
por: Zhao, Xiaoting, et al.
Publicado: (2020)

Zyxin Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma via Rap1-Mediated Inhibition of the MEK/ERK Signaling Pathway
por: Wei, Zhun, et al.
Publicado: (2023)

Porcine deltacoronavirus activates the Raf/MEK/ERK pathway to promote its replication
por: Jeon, Ji Hyun, et al.
Publicado: (2020)

Hematopoietic cell kinase enhances osteosarcoma development via the MEK/ERK pathway
por: Liu, Weibo, et al.
Publicado: (2021)

Corrigendum: EXOSC5 as a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer via Activating the ERK and AKT Pathways
por: Pan, Hongda, et al.
Publicado: (2021)

PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway
por: Cao, Huijun, et al.
Publicado: (2022)

KIF23 Promotes Gastric Cancer by Stimulating Cell Proliferation
por: Li, Xiao-Long, et al.
Publicado: (2019)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tac9g9475h4bi5crsoei15cad5